Cargando…
Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet
Autores principales: | Otoul, Christian, Watanabe, Shikiko, McCabe, Suzanne, Stockis, Armel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093258/ https://www.ncbi.nlm.nih.gov/pubmed/27274002 http://dx.doi.org/10.1002/cpdd.275 |
Ejemplares similares
-
Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers
por: Radicioni, Milko, et al.
Publicado: (2017) -
Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
por: Schoemaker, Rik, et al.
Publicado: (2017) -
Extrapolation of a Brivaracetam Exposure–Response Model from Adults to Children with Focal Seizures
por: Schoemaker, Rik, et al.
Publicado: (2017) -
Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010) -
A relative bioavailability study of 500 mg calcium p-aminosalicylate film coating tablet in healthy individuals
por: Cheng, Chinhwa, et al.
Publicado: (2013)